High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime
- 1 February 2017
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 101 (2), 430-436
- https://doi.org/10.1097/tp.0000000000001129
Abstract
Background High intrapatient tacrolimus variability has been associated with worse clinical outcomes postrenal transplantation. Theoretically, tacrolimus levels consistently outside the target therapeutic window may result in allograft dysfunction as subtherapeutic tacrolimus levels predispose to episodes of acute rejection, whereas supratherapeutic levels may cause nephrotoxicity. Methods We investigated the effect of tacrolimus variability in a “Symphony” style low-dose tacrolimus based regime, by collecting data from 432 patients over a 4-year period. Three hundred seventy-six patients were included, with a mean follow-up of 1495 days. Tacrolimus variability 6 to 12 months after renal transplantation was calculated, and outcomes were compared in low (n = 186) and high variability (n = 190) groups. Results High variability patients were found to be at increased risk of rejection during the first posttransplant year (P = 0.0054) and to have reduced rejection-free survival (hazard ratio, 1.953; 95% confidence interval, 1.234-3.093; P = 0.0054). High variability patients had significantly worse (P < 0.0001) glomerular filtration rates at 1, 2, 3, and 4 years posttransplant. High variability patients were at increased risk of allograft loss (hazard ratio, 4.928; 95% confidence interval, 2.050-11.85; P = 0.0004). Conclusions This suggests that highly variable tacrolimus levels predict worse outcomes postrenal transplantation, although the causal nature of this relationship remains unclear. High tacrolimus variability may identify a subset of patients who warrant increased surveillance and patient education regarding dietary and medication compliance.Keywords
This publication has 18 references indexed in Scilit:
- Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT)Transplantation, 2013
- Lower Variability of Tacrolimus Trough Concentration After Conversion From Prograf to Advagraf in Stable Kidney Transplant RecipientsTransplantation, 2011
- Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older childrenPediatric Transplantation, 2010
- Transplant Outcomes and Economic Costs Associated with Patient Noncompliance to ImmunosuppressionAmerican Journal of Transplantation, 2009
- Selective Retransplant After Graft Loss to Nonadherence: Success with a Second ChanceAmerican Journal of Transplantation, 2009
- Transitioning health care responsibility from caregivers to patient: A pilot study aiming to facilitate medication adherence during this processPediatric Transplantation, 2008
- Reduced Exposure to Calcineurin Inhibitors in Renal TransplantationThe New England Journal of Medicine, 2007
- Factors Contributing to Acute Rejection in Renal Transplantation: The Role of NoncomplianceTransplantation Proceedings, 2005
- Guidelines for the treatment and management of new‐onset diabetes after transplantation1Clinical Transplantation, 2005
- The pathobiology of chronic allograft nephropathy: Immune-mediated damage and accelerated agingKidney International, 2004